Physician profile
Chris Hammond
NPI 1093043143
$3,335.20
in general payments reported to CMS, 2019-2025
18 companies · $160 in 2025
The $160 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $436 · 2020: $88.82 · 2021: $1,323 · 2022: $554 · 2023: $519 · 2024: $255 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $749 · Gift: $169 · Education: $16.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $749.24 |
| Gift | $168.53 |
| Education | $16.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $1,302.94 | 2021-2023 | Opalescence |
| Inspire Medical Systems, INC. | $613.27 | 2021-2024 | Inspire |
| Novartis Pharmaceuticals Corporation | $268.98 | 2019-2025 | |
| Emd Serono, INC. | $264.27 | 2019 | |
| Ivoclar Vivadent, INC. | $231.10 | 2023 | |
| Philips North America LLC | $115.00 | 2019 | |
| Livanova USA, INC. | $92.60 | 2020-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Alexion Pharmaceuticals, INC. | $62.74 | 2025 | Ultomiris |
| Mdd US Operations, LLC | $60.43 | 2019-2020 | |
| Upsher-Smith Laboratories LLC | $56.54 | 2021-2022 | |
| Biogen, INC. | $53.26 | 2022-2023 | Vumerity, Tysabri |
| Teva Pharmaceuticals USA, INC. | $49.96 | 2020-2024 | Ajovy |
| Straumann USA LLC | $44.43 | 2021 | |
| Axsome Therapeutics, INC. | $40.11 | 2023-2025 | Sunosi |
| Lilly USA, LLC | $29.37 | 2022-2023 | Reyvow, Emgality |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itf Therapeutics LLC | $19.17 | 2024 | |
| Jazz Pharmaceuticals INC. | $16.57 | 2021 | |
| Genentech USA, INC. | $14.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Hammond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.